v3.26.1
SCHEDULE OF BUSINESS SEGMENT (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Segment Reporting [Line Items]      
Total assets $ 45,786,134   $ 44,577,873
Total revenue 5,168,036 $ 3,169,920  
Net loss (1,451,973) (616,458)  
Loss on legal settlement (18,250)  
Gain from extinguishment 1,863,834  
Interest expense (973,003) (889,792)  
Operating Segments [Member]      
Segment Reporting [Line Items]      
Total revenue 5,164,187 3,161,431  
Net loss 406,960 (867,603)  
HealthCares [Member]      
Segment Reporting [Line Items]      
Total assets 41,824,419   40,869,803
Total revenue 4,798,551 3,161,431  
Net loss 296,914 (844,598)  
Life Science Services [Member]      
Segment Reporting [Line Items]      
Total assets 3,830,873   3,648,500
Total revenue 361,250  
Net loss 142,416  
Labs [Member]      
Segment Reporting [Line Items]      
Total assets 19,034   15,854
Total revenue 4,386 8,489  
Net loss (32,370) (23,005)  
Corporate Segment and Other Operating Segment [Member]      
Segment Reporting [Line Items]      
Total assets 111,808   $ 43,716
Total revenue 3,849  
Net loss (867,680) (722,897)  
Loss on legal settlement [Member]      
Segment Reporting [Line Items]      
Total revenue  
Gain from extinguishment of Senior PIK Notes [Member]      
Segment Reporting [Line Items]      
Total revenue  
Interest expense [Member]      
Segment Reporting [Line Items]      
Total revenue